The value of stem cells in laboratory and clinical research has been clearly demonstrated through numerous studies, showcasing their potential as models for a wide range of diseases and therapeutic developments. The inherent flexibility of stem cells allows for the development of various tissue types from a single, highly proliferative base cell type. Differentiation of induced pluripotent stem cells (iPSCs) into somatic tissues requires specific conditions tailored to the desired tissue type.

Register now for this webinar ‘From iPSCs to organoids: Streamlined hepatic differentiation techniques’ on 12 November 4pm GMT / 11am EST, hosted by DDW and supported by Sartorius.

In this webinar, Daryl Cole, Scientist, Application Development at Sartorius, will describe the process of differentiating human iPSCs into hepatocytes using three distinct media types, each supplemented with specific growth factors and cytokines at key stages of differentiation. This method provides a relatively straightforward approach to producing mature hepatic cells, enabling the generation of human hepatic organoids from these source cells. This demonstrates a robust method for unlimited organoid development.

Cole has over 15 years of experience in a range of scientific fields from cancer research to organoid and stem cell development.

Key takeaways:

• How to differentiate iPSCs into hepatic lineage cells and organoids
• Best practices for monitoring differentiation, while confirming lineage and function
• Dissociation of complex 3D structures into healthy single cells for analysis
• How Sartorius products can aid in the simplification and development of robust protocols for organoid production

Register now to save your place and join the live Q&A after the presentation.